Pharmaceutical giant Pfizer has unveiled encouraging mid-stage trial results for berobenatide, an experimental anti-obesity and diabetes drug designed to be taken just once a month. If approved, it ...

WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. (NewsNation) — Some drugmakers are working on a potential breakthrough for people who take weight loss drugs: fewer injections.

Pfizer and Amgen are developing GLP-1 treatments that could be taken monthly, rather than weekly like current drugs such as Ozempic, Wegovy and Zepbound. The companies say the goal is to make the ...